V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160011924 | 160015302 | 0 | 64 | null | 2018-01-07 | 2018-04-17 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101650182 |
| 160011927 | 160015303 | 1.59 | 67.2 | Palliative (P) | 2018-02-11 | 2018-02-12 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101634702 |
| 160011931 | 160015304 | 1.89 | 93 | null | null | 2019-11-29 | Doxorubicin 75mg/m2 | 02 | null | DOXORUBICIN | 100837576 |
| 160011936 | 160015305 | 1.83 | 63 | null | 2018-01-23 | 2018-04-23 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101814689 |
| 160011938 | 160015306 | 1.74 | 78.5 | null | 2018-07-04 | 2020-03-04 | VINORELBINE | 01 | null | VINORELBINE | 100718439 |
| 160011949 | 160015307 | 1.62 | 85.6 | null | 2021-10-22 | 2021-11-25 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100037829 |
| 160011966 | 160015308 | 1.77 | 65.2 | Palliative (P) | 2020-08-29 | 2020-09-05 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100518195 |
| 160011968 | 160015309 | 1.67 | 86.1 | Palliative (P) | 2020-11-14 | 2020-11-28 | OST Euramos 1 Closed Trial - A | 02 | N | DOXORUBICIN | 101480548 |
| 160011971 | 160015310 | 1.79 | 68 | Palliative (P) | 2019-08-28 | 2019-08-28 | Doxorubin 50mg/m2 | 02 | N | TRABECTEDIN | 101645339 |
| 160011973 | 160015311 | 1.7 | null | Palliative (P) | 2019-09-28 | 2019-09-30 | Doxorubicin 75mg/m2 | 02 | N | VINORELBINE | 100453317 |
| 160011974 | 160015312 | 1.68 | 84 | Palliative (P) | 2019-02-02 | 2019-02-04 | Trabectedin | 02 | N | TRABECTEDIN | 101795818 |
| 160011977 | 160015313 | 1.68 | 112 | Palliative (P) | null | null | DOXORUBICIN | 02 | N | DOXORUBICIN | 100634324 |
| 160011992 | 160015314 | 1.52 | 81.7 | Palliative (P) | 2020-11-26 | 2021-06-17 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101523840 |
| 160011995 | 160015315 | 1.64 | 79 | Palliative (P) | 2020-11-26 | 2020-12-09 | Doxorubicin 75mg/m2 | 02 | N | TRIAL UNSPECIFIED | 100136868 |
| 160012002 | 160015316 | 1.57 | 109 | Palliative (P) | 2021-10-01 | 2021-10-03 | Vinorelbine (oral) | 02 | N | VINORELBINE | 100305802 |
| 160012006 | 160015317 | 1.73 | 77.3 | Palliative (P) | 2018-03-02 | 2018-12-04 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100449654 |
| 160012007 | 160015318 | 1.72 | 90.6 | null | null | null | NIVOLUMAB | 02 | null | NIVOLUMAB | 101083463 |
| 160012038 | 160015320 | 1.72 | 97 | Palliative (P) | 2019-07-07 | 2019-07-30 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100765298 |
| 160012040 | 160015321 | 1.79 | 57 | null | 2018-05-18 | 2018-05-24 | DOXORUBICIN | null | null | TRABECTEDIN | 100477717 |
| 160012042 | 160015322 | 1.69 | 66 | 03 | 2019-04-23 | 2019-04-25 | Doxorubicin 75mg/m2 | 02 | N | TRIAL UNSPECIFIED | 101758407 |
| 160012044 | 160015323 | 1.59 | 81.85 | null | 2020-02-29 | 2020-03-01 | Trial Unspecified | 02 | null | TRIAL UNSPECIFIED | 101477676 |
| 160012049 | 160015324 | 1.61 | 74 | null | 2021-02-23 | 2021-10-14 | Vinorelbine (oral) | 02 | null | VINORELBINE | 100738452 |
| 160012050 | 160015325 | 1.68 | 67.5 | Palliative (P) | null | 2017-07-04 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100521574 |
| 160012054 | 160015326 | 1.56 | 77.6 | Palliative (P) | null | null | Vinorelbine (oral) | 02 | N | VINORELBINE | 100323665 |
| 160012056 | 160015327 | 1.73 | 46.7 | Palliative (P) | 2018-04-08 | 2018-04-10 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100249305 |
| 160012061 | 160015328 | 1.68 | 85.65 | Palliative (P) | 2021-04-26 | 2021-04-28 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100760270 |
| 160012071 | 160015329 | 1.68 | 60.4 | Palliative (P) | 2019-12-23 | 2020-06-11 | Trabectedin | 02 | N | TRABECTEDIN | 100001263 |
| 160012075 | 160015330 | 1.68 | 122.6 | Palliative (P) | 2019-08-23 | 2019-08-23 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101845743 |
| 160012077 | 160015331 | 1.65 | 83.6 | 03 | 2017-05-08 | 2017-05-13 | DOXORUBICIN | 02 | null | TRABECTEDIN | 100638902 |
| 160012082 | 160015332 | null | 88.1 | Palliative (P) | 2019-06-30 | 2019-07-18 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100670599 |
| 160012085 | 160015333 | 1.72 | 68 | Palliative (P) | 2018-07-30 | 2018-08-04 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100518648 |
| 160012098 | 160015334 | 1.72 | 83.2 | null | 2018-01-27 | 2018-01-27 | Doxorubicin 75mg/m2 | 02 | null | DOXORUBICIN | 100434021 |
| 160012104 | 160015335 | 1.79 | 66.1 | null | null | 2017-11-03 | Trabectedin | 02 | null | TRABECTEDIN | 101420529 |
| 160012106 | 160015336 | 1.63 | null | Palliative (P) | 2020-09-25 | 2020-09-27 | Vinorelbine IV | 02 | N | VINORELBINE | 100274103 |
| 160012109 | 160015337 | 1.77 | 68.2 | null | 2018-09-15 | 2018-09-29 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100859972 |
| 160012114 | 160015338 | 1.68 | 103.2 | null | 2019-08-18 | 2019-08-18 | Vinorelbine (oral) | 02 | null | VINORELBINE | 101207306 |
| 160012118 | 160015339 | 1.72 | 83.3 | Palliative (P) | 2018-09-26 | 2018-10-03 | Trabectedin | 02 | N | TRABECTEDIN | 101387361 |
| 160012127 | 160015340 | 1.75 | 98.8 | Palliative (P) | 2020-11-01 | 2020-11-09 | Doxorubicin 75mg/m2 | 02 | N | TRABECTEDIN | 100571727 |
| 160012128 | 160015341 | 1.53 | 106.8 | null | 2021-04-01 | 2021-10-31 | DOXORUBICIN | 02 | null | VINORELBINE | 100878492 |
| 160012129 | 160015342 | 1.68 | 68.2 | Palliative (P) | 2019-06-22 | 2019-08-17 | Vinorelbine (oral) | 02 | N | VINORELBINE | 100279945 |
| 160012133 | 160015343 | 1.9 | 57.45 | null | 2021-05-29 | 2021-05-29 | Doxorubicin 75mg/m2 | 02 | null | NIVOLUMAB | 101269522 |
| 160012141 | 160015344 | 1.93 | 50.6 | Palliative (P) | null | null | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100677858 |
| 160012142 | 160015345 | 1.72 | 74 | Palliative (P) | 2021-01-09 | 2021-01-10 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100754439 |
| 160012153 | 160015346 | 1.61 | 89 | null | 2019-12-22 | 2020-01-08 | DOXORUBICIN | 02 | null | TRIAL UNSPECIFIED | 100603299 |
| 160012160 | 160015347 | 1.83 | 64.1 | Palliative (P) | 2020-04-29 | 2020-04-29 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100926246 |
| 160012170 | 160015348 | 1.56 | 71.3 | null | 2018-08-20 | 2018-08-21 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100055322 |
| 160012177 | 160015349 | 1.83 | 63 | null | 2017-06-16 | 2017-06-17 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100569435 |
| 160012180 | 160015350 | 1.68 | 73.8 | Palliative (P) | 2020-08-21 | 2020-08-21 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100361780 |
| 160012181 | 160015351 | 1.78 | 78.6 | null | null | 2021-12-03 | NIVOLUMAB | 02 | null | NIVOLUMAB | 101429665 |
| 160012190 | 160015352 | 1.63 | 73 | Palliative (P) | 2018-12-24 | 2019-06-26 | Trabectedin | 02 | null | TRABECTEDIN | 101542188 |